¼¼°èÀÇ ½Å»ý¾Æ ¸ð´ÏÅ͸µ ½ÃÀå : ±â¼ú Çõ½Å°ú ¼ºÀå ±âȸ
Neonatal Monitoring: Technology Innovation and Growth Opportunities
»óǰÄÚµå : 1308050
¸®¼­Ä¡»ç : Frost & Sullivan
¹ßÇàÀÏ : 2023³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 69 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,786,000
Web Access (Regional License) help
Frost & SullivanÀÇ À¥»çÀÌÆ® ·Î±×ÀÎ ÆÐ½º¿öµå°¡ ¹ßÇàµÇ¸ç, PDF¸¦ ´Ù¿î·Îµå ¹Þ´Â ÇüÅ·ΠÁ¦°øµÉ ¿¹Á¤ÀÔ´Ï´Ù. PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ ¸ðµç ºÐµéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù


Çѱ۸ñÂ÷

½Ç½Ã°£ Çǵå¹é°ú Áö´ÉÀûÀÎ ÀÇ»ç °áÁ¤À» Á¦°øÇÏ´Â AI ´ëÀÀ ºñħ½ÀÀû ¸ð´ÏÅ͸µÀº Çõ½ÅÀûÀÎ ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù.

½Å»ý¾Æ ¸ð´ÏÅ͸µ(Neonatal Monitoring) ÀÇ·á ±â¼úÀº »ýÈÄ ¸çÄ¥ ¸î ÁÖ µ¿¾È ½Å»ý¾Æ °Ç°­°ú »ýü ½ÅÈ£¸¦ ¸ð´ÏÅ͸µÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ½Å»ý¾Æ ÁýÁß Ä¡·á½Ç(NICU), ±âŸ º´¿ø ¶Ç´Â °¡Á¤¿¡¼­ »ç¿ëµË´Ï´Ù. ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â ½Å»ý¾Æ °¨½Ã ÀåÄ¡¿¡´Â ½ÉÀüµµ(ECG) ¸ð´ÏÅÍ ÆÞ½º »ê¼Ò ÃøÁ¤±â, ¸ð´ÏÅÍ Ã¼¿Â, ¸ð´ÏÅÍ È£Èí ¸ð´ÏÅÍ µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº À¯¾Æ ȯ°æ ´Ù¾çÇÑ ÀÚ±ØÀ¸·Î ÀÎÇÑ °Ç°­ »óÅ º¯È­¸¦ ¸ð´ÏÅ͸µÇÏ°í ¹ß´Þ ÀÌÁ¤Ç¥¸¦ ÃßÀûÇÕ´Ï´Ù. ½Å»ý¾Æ »ý¸í°ú °Ç°­ »óŸ¦ ¸ð´ÏÅ͸µÇÏ¸é ½Å¼ÓÇÑ Ä¡·á°¡ ÇÊ¿äÇÑ °Ç°­ »óÅ Á¶±â ¹ß°ßÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ÁßÁõ ½Å»ý¾Æ °Ç°­ »óÅÂ¿Í °æ°ú¸¦ ÃßÀûÇÏ¿© º´¿ø°ú °¡Á¤¿¡¼­ÀÇ ½Å»ý¾ÆÀÇ ¾ÈÀüÇÑ À̵¿À» º¸ÀåÇÏ´Â µ¥ Áß¿äÇÕ´Ï´Ù.

½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â¼úÀº Àúħ½À¼º, ħ½À¼º ¹× ºñħ½À¼ºÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÇöÀç ½Å»ý¾Æ ¸ð´ÏÅ͸µÀº Àúħ½À ±â¼ú »ç¿ëÀÌ Ç¥ÁØÀÌÁö¸¸, ¾÷°è´Â À¯¾Æ ÄèÀû¼º Çâ»ó°ú °¨¿° ¸®½ºÅ© Àú°¨, ºÎ¸ð Á¤½ÅÀû ½ºÆ®·¹½º °æ°¨, Çコ Äɾî Àü¹®°¡ »ç¿ë ¿ëÀÌÇÔ µî ¸î °¡Áö ÀåÁ¡À» Á¦°øÇÏ´Â ºñħ½À ±â¼ú·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ Frost& Sullivan ¿¬±¸´Â ´Ù¾çÇÑ ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â¼ú¿¡ ÁßÁ¡À» µÓ´Ï´Ù. ½Å»ý¾Æ ¸ð´ÏÅ͸µ ¼ö¿ä°¡ ³ôÀº ¿þ¾î·¯ºí ±â±â¿Í ºñÁ¢ÃËÇü ±â±â µî ÁÖ¿ä ºñħ½À¼º ±â±â¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø ¹× ¾ïÁ¦ ¿äÀÎÀ» °ËÁõÇÕ´Ï´Ù.

¶ÇÇÑ ÃæÁ·µÇÁö ¾ÊÀº ½ÃÀå ¿ä±¸, ÁÖ¿ä ¸ð´ÏÅ͸µ ¼ö´Ü, ¿þ¾î·¯ºí ¹× ºñÁ¢ÃË½Ä ÀåÄ¡ »ç·Ê, ½Å±â¼ú ¹× »õ·Î¿î ÀåÄ¡ Æò°¡ ¸Å°³º¯¼ö¸¦ Æò°¡ÇÕ´Ï´Ù.

½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â±â ÀÓ»ó½ÃÇè ºÐ¼®, Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú(PEST) ºÐ¼®, °í°´ ¿©Á¤ ¸ÅÇÎ, ¹Ì·¡ ±â¼ú Àü¸Á, ƯÇã Á¤¼¼¿¡µµ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÃÀå ÁøÃâ±â¾÷ Áß¿ä ¼ºÀå ±âȸµµ ¹àÇôÁö°í ÀÖ½À´Ï´Ù.

ÀÌ ¼³¹®Á¶»ç°¡ ´äº¯ÇÏ´Â ÁÖ¿ä Áú¹®:

¸ñÂ÷

Àü·« °úÁ¦

¼ºÀå ±âȸ ºÐ¼®

ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ : ¿þ¾î·¯ºí ±â±â

ºñħ½ÀÀû ½Å»ý¾Æ ¸ð´ÏÅ͸µ : ºñÁ¢ÃË½Ä ÀåÄ¡

¾÷°è Æò°¡ ¹× ºÐ¼®

ƯÇã »óȲ

¼ºÀå ±âȸ À¯´Ï¹ö½º

ºÎ·Ï

´ÙÀ½ ´Ü°è

NJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

AI-enabled Noninvasive Monitoring that Offers Real-time Feedback and Intelligent Decision-making Drives Transformational Growth.

Neonatal monitoring medical technologies monitor newborn babies' health and vital signs in the first few days or weeks of their life. These technologies are used in neonatal intensive care units (NICUs) and other hospital settings or at home. Some commonly used neonatal monitoring devices include electrocardiography (ECG) monitors, pulse oximetry monitors, temperature monitors, and respiratory monitors. Such technologies monitor health changes caused by various stimuli in a baby's environment and track development milestones. Monitoring a newborn's vitals and health is important as it enables early detection of health conditions that require immediate medical attention; tracks critically ill infants' health and progress; and ensures the safe transition of the newborn from hospital to home.

Neonatal monitoring technologies can be minimally invasive, invasive, and noninvasive. Though the current standard for neonatal monitoring is to use minimally invasive technologies, the industry is shifting to noninvasive technologies that offer several benefits, including increased comfort and reduced infection risk for the baby, less emotional stress for the parents, and ease of use for healthcare professionals.

This Frost & Sullivan study highlights different noninvasive neonatal monitoring technologies. It focuses on key noninvasive devices, including wearable and contactless devices in high demand for neonatal monitoring.

The study examines factors that drive and restrain market growth.

It also evaluates unmet market needs, key monitoring measures, examples of wearable and contactless devices, emerging technologies, and evaluation parameters for a novel device.

The study highlights the clinical trial analysis of neonatal monitoring devices; political, economic, social, and technological (PEST) analysis; customer journey mapping; future technology outlook; and patent landscape. In addition, it identifies significant growth opportunities for market participants.

Key Questions This Study Answers:

Table of Contents

Strategic Imperatives

Growth Opportunity Analysis

Noninvasive Neonatal Monitoring, Wearable Devices

Noninvasive Neonatal Monitoring, Contactless Devices

Industry Assessment and Analysis

Patent Landscape

Growth Opportunity Universe

Appendix

Next Steps

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â